跳至主要内容
临床试验/NCT01014390
NCT01014390已完成3 期

A Multi-Center, Prospective Study of the WallFlex Biliary RX Fully Covered Stent for the Treatment of Benign Biliary Strictures

Boston Scientific Corporation13 个研究点 分布在 11 个国家目标入组 187 人开始时间: 2009年12月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
187
试验地点
13
主要终点
Stent Removability

研究概览

简要总结

The purpose of this study is to evaluate the safety and performance of the WallFlex® Biliary RX Fully Covered Stent as a treatment of biliary obstruction resulting from benign bile duct strictures.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 18 or older
  • •Willing and able to comply with the study procedures and provide written informed consent to participate in the study
  • •Chronic pancreatitis or prior liver transplantation or prior other abdominal surgery (to include cholecystectomy)
  • •Indicated for ERCP procedure with stent placement for: Symptomatic bile duct stricture (i.e. obstructive jaundice, persistent cholestasis, acute cholangitis) confirmed by cholangiogram and/or Bile duct stricture confirmed by cholangiogram and/or Exchange of prior plastic stent(s) for management of benign stricture

排除标准

  • •Placement of the stent in strictures that cannot be dilated enough to pass the delivery system
  • •Placement of the stent in a perforated duct
  • •Placement of the stent in very small intrahepatic ducts
  • •Patients for whom endoscopic techniques are contraindicated
  • •Biliary stricture of malignant etiology
  • •Biliary stricture of benign etiology other than chronic pancreatitis or liver transplant anastomosis or other abdominal surgery
  • •Stricture within 2 cm of duct bifurcation
  • •Symptomatic duodenal stenosis (with gastric stasis)
  • •Prior biliary self-expanding metal stent
  • •Suspected stricture ischemia based on imaging of hepatic artery occlusion or endoscopic evidence of biliary cast syndrome
  • •Known bile duct fistula
  • •Known sensitivity to any components of the stent or delivery system
  • •Participation in another investigational study within 90 days prior to consent or during the study
  • •Additional Specific to Chronic Pancreatitis Patients:
  • •Developing obstructive biliary symptoms associated with an attack of acute pancreatitis
  • •Additional Specific to Post-Abdominal Surgery Patients:
  • •History of hepatectomy
  • •History of liver transplant
  • •Additional Specific to Liver Transplant Patients:
  • •Live donor transplantation

研究组 & 干预措施

WallFlex Biliary RX FC Stent System

Experimental

The WallFlex Biliary RX Fully Covered Stent System is being evaluated for treatment of benign biliary strictures.

干预措施: WallFlex Biliary RX Fully Covered Stent System (Device)

结局指标

主要结局

Stent Removability

时间窗: At stent removal

Defined as ability to remove the stent endoscopically without serious stent removal related adverse events as assessed from the time of stent removal to 1month post-stent removal.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验